NL003-CLI-III-2

· Beijing Northland Biotech. Co., Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for NL003-CLI-III-2, covering 2024-09-20 to 2024-09-20. Get the full timeline:

Most recent: Clinical Trial Update: Safety and Efficacy Study Using Gene Therapy for Critical Limb Ischemia (NL003-CLI-III-2) [Phase 3]